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ABSTRACT
International Journal of Exercise Science 11(3): 95-105, 2018. Our aim was to investigate the acute
effects of a single bout of high intensity intermittent training (HIIT) on glucose tolerance and other physiological
and metabolic markers in non-diabetic older adults. Fourteen healthy older adults (age, 64 ± 2 y; BMI, 25.7 ± 2.8
kg·m-2) performed two acute exercise trials: continuous moderate intensity exercise (MOD) and HIIT, with the
response to an oral glucose tolerance test (OGTT) determined <24 hours after. Inflammatory, haematological, and
lipid parameters were also assessed the day after each trial. There was an effect of the trials on the insulin response
to an OGTT (P=0.047), but not the glucose response. Following an acute bout of HIIT, insulin concentration during
an OGTT was elevated at 60 min compared to the control trial (P=0.045), indicating more insulin was secreted, but
glucose concentration was unchanged in all trials. The study findings demonstrate that a single bout of HIIT affects
the insulin response but not the glycaemic response to a glucose load, proffering a potential benefit for metabolic
health in older adults.
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INTRODUCTION
Ageing is one of the biggest social issues in Europe. There is a disparity between life expectancy
and healthy life expectancy which is being exacerbated by high levels of inactivity in the older
population. An inactive lifestyle and sedentary behaviour are reported to be among the leading
causes of chronic disease (3). Scotland has the highest proportion of people aged over 60 years
in the UK and therefore finding innovative solutions to improve quality of life are needed. The
most recent public health guidelines from the American Heart Association (AHA) and the
American College of Sports Medicine (ACSM) advocate that regular physical activity is essential
for healthy ageing (26).
The main pathophysiological events in the development of type 2 diabetes are a reduction in
insulin secretion and/or the decline in insulin sensitivity (12). This can result in a decline in
glucose tolerance and thus hyperglycaemic state, leading to the predisposed state for the
development of diabetes. It is known that glucose tolerance deteriorates with age, which is of
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importance for older adults as diabetes is associated with increased mortality and demand on
the National Health Service (NHS) for treatment. However, preventative measures should be
adopted in order to improve glucose tolerance in older adult years (60-75 years) to prevent or
delay the onset of diabetes in elderly years (75 years +).
Resistance and endurance exercise have been shown to improve functional outcomes (24),
cognitive function (13), arterial stiffness (18), and glucose metabolism (4) in older adults. High
intensity intermittent training (HIIT) involving repeated short bouts of high intensity exercise
(above 85% of maximal capacity), has been shown to provide similar, and in some cases greater,
physiological and metabolic adaptations that influence systemic glucose control compared to
moderate intensity continuous exercise (MOD) (2, 5, 16, 25). Furthermore, 6 weeks of HIIT in 6075 year olds has been shown to improve physical function, lower blood pressure and improve
self-reported health (2). The response and adaptations have mainly been investigated using an
oral glucose tolerance test (OGTT), which reports systemic insulin and glucose concentrations
in response to a high glucose load, indicating insulin secretion in to the circulation from beta
cells and glucose uptake from the circulation, thus systemic glucose tolerance.
Ageing is also associated with an increase in inflammatory proteins within the circulation,
which can lead to chronic low-grade inflammation. This inflammatory state can be reflected by
increased systemic concentration of some cytokines such as interleukin-6 (IL-6) and tumor
necrosis factor alpha (TNF-α), and C-reactive protein (CRP) concentration (28), and also
underlies the development of type 2 diabetes. Previous research has shown that acute and
chronic exercise can induce anti-inflammatory effects (14, 15). However, the acute response to
HIIT has not yet been investigated in a non-diabetic older adult population.
The primary purpose of this study was to determine if there is a difference in the acute metabolic
response to MOD and HIIT by examining the response to an OGTT and effect on key
inflammatory markers.
METHODS
Participants
Sixteen healthy male (n=12) and female (n=4) volunteers with a body mass index (BMI) between
20-30 kg·m2 were recruited for the study, and of those, 14 participants completed the control
trial and both exercise trials as prescribed (mean ± SD: age 64 ± 2 y, body mass 80.1 ± 11.2 kg,
height 1.77 ± 0.09 m, BMI 25.7 ± 2.8 kg·m-2). Volunteers were excluded if they smoked, or were
taking medications that would alter blood parameters, otherwise all participants were healthy
and recreationally active. Informed consent was obtained from all individual participants
included in the study. The study was approved by the School of Applied Sciences Research
Integrity Approvals Group at Edinburgh Napier University and followed procedures in
accordance with the ethical standards of the Helsinki Declaration.
An a priori power analysis using GPower software 3.1.9.2 was performed for sample size
estimation based on an ANOVA: 3 (control, endurance, HIIT) x 5 (OGTT time-points) repeated
International Journal of Exercise Science

96

http://www.intjexersci.com

Int J Exerc Sci 11(3): 95-105, 2018
measures, within factors statistical test (F test). The projected sample size required for the
statistical test was n=12, to achieve power of 0.99 and effect size f of 0.50 (Cohen’s f).
Protocol
Baseline testing: Participants attended the laboratory between 0730-0900 following an overnight
fast (≥10 h) for baseline testing, involving basic anthropometric measurements, a standard oral
glucose tolerance test (OGTT), and a maximal exercise test (V̇O2peak test), and a familiarisation
HIIT protocol. Participants were asked to abstain from consuming caffeine and alcohol in the 24
h prior to the first visit, and engaging in strenuous exercise in the 72 h prior to the first visit. On
arrival, participant’s height (Harpenden Portable, Holtain Limited, UK), body mass (Seca, 808,
Germany), and waist and hip circumference were measured. Arterial blood pressure was
measured on the participant’s non-dominant arm (Omron, R5-1, Japan) following a 5 min rest
in the supine position. Following anthropometric measurements, participants were seated on a
laboratory bed to complete a standard 75 g OGTT. A cannula (20 G Venflon Pro Safety I.V.
cannula, BD, Sweden) was inserted into the antecubital vein and fasted blood samples were
collected into K3 ethylenediaminetetraacetic acid (EDTA) (approximately 1.0 mg) and sodium
fluoride/potassium oxalate vacutainers, then participants consumed 82.5 g of dextrose
monohydrate dissolved in 290 ml of water and 10 ml of lemon juice within 5 min. Further blood
samples were subsequently taken every 30 min for a period of 2 h, with the cannula kept patent
via regular flushing with 0.9% saline solution. Participants remained seated and rested during
the 2 h test.
Participants performed a peak oxygen uptake test (V̇O2peak) using a continuous incremental
exercise test on a stationary electromagnetically-braked cycle ergometer (Lode, Corival CPET,
Netherlands). An on-line breath-by-breath gas analysis system (Cortex, MetaLyzer 3B,
Germany) was used to measure expired air continuously throughout the test, and heart rate
(HR) was monitored by a chest worn HR monitor (Polar, RS400, Finland) and the HR sensor
linked to the gas analysis system. After a 5 min warm up at 50 W, the intensity increased by 2530 W every 3 min until volitional exhaustion (30). Participants were instructed to maintain a
pedaling rate of 70 revolutions per min (rpm) and were verbally encouraged to perform to
volitional exhaustion whereby the test was terminated (pedaling rate fell below 55 rpm). The
value used for V̇O2peak corresponded to the highest value averaged over 30 s during the test. In
the same session, following a 30 min rest period, participants performed a familiarisation trial
for the HIIT protocol, involving four 1 min intervals.
Exercise sessions: All participants performed two exercise trials in a randomised, counter
balanced fashion: MOD and HIIT (Figure 1), separated by 7-8 days. Participants attended the
lab to complete the exercise trial between 0730-0900. Body mass and arterial blood pressure were
measured on arrival to the laboratory. Both protocols were performed on a cycle ergometer
(Lode, Corival CPET, Netherlands), with expired air (Cortex, MetaLyzer 3B, Germany) and HR
continuously throughout both exercise trials.
The HIIT protocol was modelled on previous studies (16, 17, 20) consisting of a 5 min warm up
at 50 W, then ten 1 minute intervals at a power output corresponding to 100% V̇O2peak,
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interspersed with 1 min at 50 W. This was concluded with a cool down of 5 min at 50 W. The
MOD protocol matched the HIIT protocol for total duration (29 min) and workload (energy cost
was not determined) and consisted of continuous cycling at ~65% of V̇O2peak.
The day after each exercise trial, participants attended the lab to repeat the OGTT between 08000930, which was dependent on the time they completed the exercise trial (ensuring it was 24 h
after).

Figure 1. Schematic diagram of the MOD and HIIT protocols.

Blood sample analysis: All assays and analysis methods were performed in duplicate. Whole
blood was analysed for full blood cell count using a haematology analyser (Sysmex, XS 1000i,
USA). Whole blood was then centrifuged (Satorius Universal, 320R, Germany) within 30 min of
collection at 1500 rpm for 15 min at 4°C, and the resulting plasma aliquoted into Eppendorf
tubes and stored at -80°C for subsequent analysis.
Plasma samples were thawed on ice prior to analysis. Commercially available enzyme-linked
immunosorbent assays (ELISA) kits were used to determine plasma insulin concentrations
(Mercodia, Uppsala, Sweden) and IL-6, TNF-α, and C-Reactive protein (CRP) (R&D Systems,
Minneapolis, USA). Plasma glucose, total cholesterol, triglyceride, and high density lipid (HDL)
cholesterol concentrations were analysed using a bench top clinical chemistry analyser (Randox,
RX Monza, UK). Low density lipid (LDL) cholesterol concentration was estimated using the
following equation: LDL cholesterol = Total cholesterol – (triglycerides/2.2) – HDL cholesterol
(10). Insulin sensitivity and insulin resistance was calculated using the insulin sensitivity index
(ISI) (22) and homeostatic model assessment-of insulin resistance (HOMA-IR) (23). Plasma and
insulin concentrations were determined at the 5 time-points involved in the OGTT. All other
blood parameters were determined at the baseline time-point of the OGTT (0 min).
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Statistical Analysis
Data are presented as means ± SD. All statistical tests were performed using SPSS 24.0 statistical
software (IBM Analytics, New York, USA). Data was checked for normal distribution using the
Shapiro-Wilk test. All data was normally distributed and parametric tests were performed. A
one-way analysis of variance (ANOVA) was used to compare means for the three trials, with
post-hoc Tukey tests for multiple comparisons between groups. A 3 x 5 repeated measures
ANOVA was also used to analyse the insulin and glucose response during the OGTT. If a
significant effect was found, post-hoc analysis was performed to identify where significance
exists between trials. If a main effect was observed when comparing two trials, paired sample ttests were used to compare trials at each time-point. Significance was accepted at P<0.05.
RESULTS
Anthropometric and performance measurements: Participant characteristics and all
performance outcomes from the V̇O2peak test (n=14, 2 females) are provided in Table 1.
Participants were normotensive and had a BMI (25.7 ± 2.8 kg·m-2) just over the classification for
overweight (>25 kg·m-2).
Table 1. Baseline participant characteristics.
Number or mean
12:2
64 ± 2
1.77 ± 0.09
80.1 ± 11.2
25.7 ± 2.8
88 ± 10
100 ± 6
64 ± 8
138 ± 9
85 ± 6
2.35 ± 0.52
29.5 ± 6.6
185 ± 32
2.33 ± 0.40
1.18 ± 0.07
159 ± 11

Males:females
Age (y)
Height (m)
Body mass (kg)
BMI (kg·m-2)
Waist circumference (cm)
Hip circumference (cm)
HR rest (bpm)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Absolute V̇O2peak (L·min-1)
Relative V̇O2peak (ml·kg-1·min-1)
Absolute peak power output (W)
Relative peak power output (W kg-1)
RER peak
HR peak (bpm)
Data are presented as mean ± SD.

Effect of exercise on glycaemic outcomes: Three participants had high fasting blood glucose
concentrations (>7.0 mmol·L-1) in the control trial, two in the HIIT trial, and none in the MOD
trial, based on the American Diabetes Association (ADA) ‘Criteria for the diagnosis of diabetes’
(1). However, none of these participants had high fasting levels on more than one trial and thus
the data was included in the analysis. Table 2 provides the biochemical analysis outcomes.
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Table 2. Blood parameters following the control, HIIT and MOD trials.
mmol·L-1

Fasting glucose,
Fasting insulin, mU·L-1
Glucose AUC, mmol·h-1·L-1
Insulin AUC, mU·h-1·L-1
ISI
HOMA-IR
IL-6, pg·ml-1
TNF-alpha, pg·ml-1
CRP, mg·L-1
Cholesterol, mmol·L-1
Triglycerides, mmol·L-1
HDL-chol, mmol·L-1
LDL-chol, mmol·L-1
Data are presented as mean ± SD.

Control
6.2 ± 0.9
5.6 ± 2.4
910 ± 197
4781 ± 3856
10.4 ± 6.0
1.57 ± 0.82
2.23 ± 0.68
1.27 ± 0.42
1.61 ± 0.94
5.5 ± 0.8
1.59 ± 0.42
1.52 ± 0.42
3.27 ± 0.83

HIIT
5.9 ± 0.9
6.9 ± 4.8
904 ± 216
5373 ± 5212
10.5 ± 7.6
1.87 ± 1.48
2.26 ± 0.76
1.13 ± 0.35
1.63 ± 0.87
5.3 ± 0.9
1.57 ± 0.35
1.50 ± 0.37
3.08 ± 0.78

MOD
5.5 ± 0.6
5.3 ± 3.3
865 ± 142
4576 ± 3681
11.6 ± 4.8
1.27 ± 0.66
2.18 ± 0.81
1.13 ± 0.34
2.14 ± 1.78
5.6 ± 0.8
1.60 ± 0.38
1.49 ± 0.38
3.40 ± 0.71

ANOVA P value
0.072
0.496
0.786
0.879
0.865
0.329
0.963
0.556
0.464
0.588
0.968
0.979
0.556

Glucose concentration (mmol·L-1)
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Figure 2. Plasma glucose concentrations in response to a 75 g OGTT for all three trials: control, MOD, and HIIT.
*Denotes a significant difference in the OGTT between trials; P<0.05.

There was no difference observed between trials for the glucose response to the OGTT (Figure
2). There was a differing response between the three trials for the insulin response to the OGTT
(P=0.047; Figure 3), with a difference found when comparing the control vs HIIT trial (P=0.045)
but not when comparing the control vs MOD trials (P=0.065) or the HIIT vs MOD trials
(P=0.140). This indicates that more insulin was produced during the HIIT trial, as shown in
Figure 3. Specifically, 24.6% more insulin was produced at 60 min during OGTT following the
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HIIT trial compared to after the control trial. Insulin sensitivity as assessed by ISIMatsuda and
HOMA-IR did not differ between trials (P=0.865; P=0.329; Table 2).
*
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Figure 3. Plasma insulin concentrations in response to a 75 g OGTT for all three trials: control, MOD, and HIIT.
*Denotes a significant difference in the OGTT between trials; P<0.05.

DISCUSSION
The main findings of the present study are that less than 24 hours after an acute bout of HIIT,
insulin secretion is increased, compared to the control trial, with 24.6% more insulin in the blood
at 60 mins post-glucose loading. There was no effect of either exercise trial on insulin sensitivity
or inflammatory markers. Although not significant, there was a physiological finding on fasting
plasma glucose concentration after the exercise trials compared to the control trial. Similarly,
following the HIIT trial, fasting plasma insulin concentration was reduced physiologically but
was not statistically significantly. All of the participants were healthy and active, however due
to a relatively small sample size with only 2 females, gender comparisons could not be
investigated. To our knowledge, this is the first study to investigate the effects of a single bout
of exercise on glycaemic control, assessed through the response to a standard 75 g OGTT, in
older adults that are free from diabetes and metabolic disease.
The findings extend the observations of exercise intervention studies involving resistance and
aerobic exercise training that have induced improvements in glycaemic control (6) and insulin
sensitivity (8, 9), and decreases in fasting glucose and insulin concentrations (11). However, the
study populations differ to the current study and thus are not largely comparable. Furthermore,
chronic adaptations do not necessarily reflect expectations for acute effects/response.
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In order to improve insulin sensitivity, it is ideal for less insulin to be produced to effectively
maintain a normal glucose concentration, or for the insulin secretion response to remain
unchanged whilst glucose concentrations decline. These scenarios would thus indicate that the
uptake of glucose is increased and cells sensitivity to insulin action to actively uptake glucose is
improved. However, our findings demonstrate that following a single bout of HIIT, more insulin
was secreted to maintain the same systemic glucose concentration. This indicates that the acute
metabolic response following HIIT is to secrete more insulin in a post-prandial state, possibly
suggesting that Beta cell action is elevated (19).
The prevalence of diabetes or a metabolic disease means that baseline glycaemic indices and
inflammatory markers will be disturbed. Therefore, exercise strategies will be prescribed as a
treatment, as opposed to the current study, which aims to employ exercise as a preventative
tactic. Since fasting values for insulin and glucose in non-diabetics are classified as normal, it is
not considered an aim of exercise to reduce fasting insulin or glucose concentrations. The aim of
the acute effect of exercise in persons exhibiting euglycaemia is thus to improve tolerance to the
glucose load through insulin secretion and action. This may explain the lack of effect on indices
of insulin sensitivity as they take into account changes in fasting concentrations. In order to
assess glycaemic control, it is suggested that insulin secretion may be a better predictor than
insulin sensitivity (29). In an intervention study in older adults, following 8 weeks of HIIT, the
response to an OGTT and fasting values remained unchanged in the non-diabetic group, but
significantly improved in the diabetic group (19). They also reported that HIIT can ameliorate
pancreatic beta cell function, however this was only in the diabetic group, again demonstrating
the effect that exercise could have as a treatment strategy. Although, following exercise, healthy
pancreatic function is normally associated with a decrease in insulin secretion relative to
improvements in insulin sensitivity. Therefore, the elevation in insulin secretion following an
acute bout of HIIT observed in the current study is controversial.
Long-term exposure to HIIT may induce an adaptation in beta cell function and subsequently
insulin secretion, and thus the acute response may merely predict that beta cells have the
capacity to respond rapidly and differently to glucose loading. A recent study has hypothesized
that the acute response to exercise may induce an early metabolic remodeling mechanism (19),
explaining the rise in systemic insulin despite the unaltered glucose response. Although, the
chronic adaptations to regular HIIT in older adults would have to be investigated to confirm
this alongside the reports of the acute effects. A study investigating the longer term effects of
endurance exercise (12-16 weeks) on pancreatic beta cell function and glycaemic control found
that glucose-stimulated insulin secretory capacity prior to initiating training predicts traininginduced adaptations (29). This supports our finding that a single bout of HIIT induced higher
insulin secretion following glucose stimulation and thus may be ascertained to glucosestimulated insulin secretory capacity. In addition, advancing age is associated with poorer beta
cell function and thus glycemic control, although insulin sensitivity was not affected by ageing
(7).
Although the present study addresses the acute response, the short term effects could then
expand to have a chronic adaptation, which future studies should investigate. If ageing is
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associated with increasing fasting glucose concentration thus disposing older adults to
hyperglycaemic risk, the ability to secrete more insulin when challenged with a high glucose
load may be beneficial to effectively modulate euglycaemia.
Exercise has been reported to be a protective tool against chronic inflammation-associated
diseases (21), which is ascribed to the anti-inflammatory effect that exercise can induce. One of
the main possible mechanisms by which exercise can induce this anti-inflammatory
environment is though the increased production and release of specific cytokines from
contracting skeletal muscle (27), known as myokines, which are designed to reduce
inflammation. However, these myokines are released at differing time-points after exercise.
Therefore, measuring concentrations of IL-6, TNF-α, and CRP at 24 h after exercise may
modestly omit the acute response. It should be considered that if only a relatively short term
effect is observed, then it may not establish change in the inflammatory environment that could
influence disease risk.
The key finding of the study was the increase in insulin secretion the day following the bout of
HIIT, which was accompanied with no change in the glycaemic response. This indicates that the
higher intensity nature of the HIIT bout may proffer an exercise-induced increase in insulin
production or insulin secretion. However, the mechanisms surrounding the lack of change in
glucose concentration in the presence of elevated insulin concentrations should be further
investigated.
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